Roche Holding Ltd. (VTX:ROG) Given a CHF 235 Price Target by Kepler Capital Markets Analysts

Kepler Capital Markets set a CHF 235 price objective on Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Tuesday, July 11th. The brokerage currently has a neutral rating on the healthcare company’s stock.

A number of other equities research analysts have also issued reports on the company. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on Roche Holding and gave the stock a buy rating in a research report on Friday, May 26th. J P Morgan Chase & Co reissued a buy rating on shares of Roche Holding in a research report on Wednesday, April 5th. Morgan Stanley set a CHF 290 price target on Roche Holding and gave the company a buy rating in a research report on Monday, May 29th. Deutsche Bank AG set a CHF 273 price target on Roche Holding and gave the company a buy rating in a research report on Tuesday, June 6th. Finally, Societe Generale set a CHF 275 price target on Roche Holding and gave the company a neutral rating in a research report on Thursday, June 29th. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of CHF 271.08.

Shares of Roche Holding (VTX:ROG) opened at 247.60 on Tuesday. The company has a market capitalization of CHK 210.95 billion and a PE ratio of 21.43. Roche Holding has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00. The stock has a 50 day moving average of CHK 247.00 and a 200-day moving average of CHK 251.21.

TRADEMARK VIOLATION NOTICE: This article was first reported by BNB Daily and is the property of of BNB Daily. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.baseball-news-blog.com/2017/07/27/roche-holding-ltd-vtxrog-given-a-chf-235-price-target-at-kepler-capital-markets-updated.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Roche Holding Ltd. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

seventeen + 11 =